GO:0071222 cellular response to lipopolysaccharide: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0071222 describes how a single cell changes its state or activity in response to lipopolysaccharide (LPS), the major component of the gram-negative bacterial cell wall.
The response is cell-type specific: monocytes, macrophages, alveolar macrophages, myotubes, shrimp haemocytes and ovine immune cells each mount distinct transcriptional, metabolic and secretory programs after LPS exposure.
LPS triggers rapid signaling through MAPK/ERK1/2 and NF-kB-dependent gene expression, and this can be modulated by environmental cues such as microgravity.
Metabolic remodeling is a core feature of the cellular LPS response, including shifts in amino acid, lipid and energy pathways in human alveolar macrophages.
The magnitude of the LPS response varies with host genetics and disease state, as shown by attenuated monocyte responses in hypertensive coronary artery disease patients.
CRISPR knockout, knock-in, point-mutation and overexpression models are essential to establish causal roles of candidate genes in the cellular response to LPS.

Description

The Gene Ontology term GO:0071222, cellular response to lipopolysaccharide, captures any process that results in a change in state or activity of a cell as a result of a lipopolysaccharide stimulus. Lipopolysaccharide (LPS) is a major component of the gram-negative bacterial cell wall and a potent trigger of innate immune signaling. Because LPS is encountered by diverse cell types, the term encompasses movement, secretion, enzyme production and gene expression changes that occur within the responding cell. Researchers use GO:0071222 to annotate and interpret transcriptomic, proteomic and functional datasets generated after LPS challenge, making it a central node in inflammation and host-defense research. The term is deliberately cell-centric: it excludes organism-level or tissue-level responses and focuses on the intracellular and cell-autonomous events that follow LPS recognition. This precision is important when comparing datasets across species and cell models, from human monocytes and macrophages to shrimp haemocytes and ovine immune cells. In practice, GO:0071222 is used to group genes and pathways whose expression or activity changes after LPS stimulation, including cytokine production, metabolic reprogramming and stress responses. As a result, it provides a shared vocabulary for immunologists, cell biologists and computational scientists who study endotoxin responses.

cellular response to lipopolysaccharide At A Glance

GO ID GO:0071222
GO term cellular response to lipopolysaccharide
Ontology biological_process
Synonym cellular response to endotoxin; cellular response to LPS
Definition Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
Major function Cell-autonomous sensing and response to LPS, including signaling, gene expression, secretion and metabolic changes
Stimulus Lipopolysaccharide (LPS), also called endotoxin
Representative cell types Monocytes, macrophages, alveolar macrophages, myotubes, haemocytes
Related disease contexts Inflammation, coronary artery disease, metabolic stress

What Is GO:0071222?

GO:0071222 is defined by QuickGO as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. In other words, it is the cell-level response to LPS, covering signaling, transcriptional, metabolic and secretory changes that occur within the responding cell.

Why Is cellular response to lipopolysaccharide Important in Cell Biology?

GO:0071222 is important because LPS is one of the most potent microbial triggers of innate immune activation, and the cellular response to LPS underlies both protective host defense and pathological inflammation. Understanding this process at the single-cell level helps researchers interpret how different cell types, genetic backgrounds and environmental conditions shape inflammatory output. It also provides a framework for identifying therapeutic targets and biomarkers in inflammatory and metabolic disease.
Defines the cell-level response to a major gram-negative bacterial cell wall component.
Enables cross-species comparison of LPS responses in monocytes, macrophages, myotubes and haemocytes.
Links LPS sensing to transcriptional and metabolic reprogramming in human alveolar macrophages.
Provides a framework for studying attenuated LPS responses in hypertensive coronary artery disease patients.
Highlights environmental modulation of LPS signaling, such as microgravity effects on monocyte ERK1/2.
Supports annotation of cytokine, chemokine and stress-response genes after endotoxin challenge.
Relevant to breed-specific and species-specific differences in immune responsiveness.
Guides CRISPR-based causal testing of candidate genes in inflammation research.

What Happens During cellular response to lipopolysaccharide?

LPS recognition and early signaling
In simple terms: The cell first detects LPS and switches on early alarm signals.
The cellular response to LPS begins when the cell senses lipopolysaccharide and activates intracellular signaling cascades. In human monocytes, microgravity activates ERK1/2 signaling and modulates the subsequent response to LPS, showing that early kinase pathways are sensitive to environmental context. In human macrophage-like cells, stimulation with Fusobacterium nucleatum lipopolysaccharide induces a measurable cellular response, confirming that diverse LPS structures can trigger this GO term. These early events set the stage for downstream gene expression and secretion.
Transcriptional and gene-network reprogramming
In simple terms: The cell changes which genes are turned on or off.
After LPS exposure, cells reprogram gene expression through coordinated gene networks. A gene network driving the attenuated response to LPS has been identified in monocytes from hypertensive coronary artery disease patients, demonstrating that host disease status can reshape the transcriptional response. Vitamin D both facilitates and attenuates the cellular response to LPS, indicating that nutritional and hormonal signals can modulate LPS-induced gene expression. These findings show that GO:0071222 includes both activation and restraint of inflammatory gene programs.
Metabolic remodeling
In simple terms: The cell changes how it uses energy and nutrients.
Metabolic pathways are a core part of the cellular response to LPS. In human alveolar macrophages, LPS exposure uncovers distinct metabolic pathway changes, linking immune activation to shifts in cellular metabolism. In myotubes, LPS-induced cell stress is accompanied by fluctuations in adenine-derived signaling molecules and cytokinins, suggesting that nucleotide-related metabolism participates in the response. Together, these studies show that GO:0071222 extends beyond classical inflammation to include metabolic adaptation.
Secretory and effector outputs
In simple terms: The cell releases signals and performs effector functions.
A defining outcome of the cellular response to LPS is secretion of cytokines, chemokines and other effectors. Human macrophage-like cells stimulated with Fusobacterium nucleatum LPS mount a secretory response consistent with this GO term. In shrimp haemocytes, different subpopulations show various cellular responses to LPS stimulation, illustrating that secretion and effector output can differ between cell types within the same organism. These outputs connect the intracellular response to intercellular communication and host defense.
Host and environmental modulation
In simple terms: The strength of the response depends on the host and its environment.
The magnitude of the cellular response to LPS is not fixed. Breed-specific differences in the immune response to LPS have been reported in ewes, showing genetic background effects. Microgravity modulates the monocyte response to LPS through ERK1/2 signaling, demonstrating environmental influence. Vitamin D can both facilitate and attenuate the response, adding a nutritional layer of control. These examples show that GO:0071222 is a dynamic, context-dependent process.

Key Genes Involved in GO:0071222 cellular response to lipopolysaccharide

The following genes and proteins are representative of the cellular response to lipopolysaccharide, based on the verified literature cited in this article.
GeneMajor RoleResearch Relevance
ERK1/2 (MAPK3/MAPK1)Early kinase signaling in monocytes exposed to LPS under microgravityReadout of environmental modulation of LPS response
Vitamin D receptor (VDR)Facilitates and attenuates the cellular response to LPSNutritional and hormonal modulation of LPS response
NF-kB componentsTranscriptional activation of inflammatory genes after LPSCore signaling node in GO:0071222
Cytokines (e.g., TNF, IL6)Secretory effectors of the LPS responseFunctional output of GO:0071222
Metabolic pathway enzymesRemodeling of amino acid, lipid and energy metabolism in alveolar macrophagesMetabolic dimension of LPS response
Adenine-derived signaling moleculesFluctuations in cytokinins in myotubes under LPS stressStress-related metabolic signaling
Monocyte gene network genesDrive attenuated LPS response in hypertensive CAD patientsDisease-specific gene network
Haemocyte subpopulation markersDifferent cellular responses to LPS in shrimp haemocytesCross-species cell-type specificity
Macrophage effector genesResponse of human macrophage-like cells to Fusobacterium nucleatum LPSMicrobial diversity in LPS response
Ovine immune response genesBreed-specific differences in LPS response in ewesHost genetics of LPS response
Alveolar macrophage metabolic genesMetabolic pathways in human alveolar macrophages after LPSLung immunity and metabolism
Myotube stress-response genesLPS-induced cell stress in myotubesMuscle-immune crosstalk
Monocyte ERK1/2 targetsMicrogravity-activated signaling and LPS modulationSpace biology and immunity
Inflammatory transcription factorsCoordinate gene expression after LPSCore regulatory layer
Secretory pathway componentsMediate cytokine release after LPSEffector mechanism
Cell-surface LPS sensing componentsInitiate the cellular response to LPSUpstream recognition
Stress-response kinasesIntegrate LPS signals with cellular stressSignaling integration
Metabolic checkpoint enzymesLink LPS response to energy metabolismTherapeutic target discovery

How Is cellular response to lipopolysaccharide Regulated?

The cellular response to lipopolysaccharide is regulated at multiple levels. Vitamin D both facilitates and attenuates the response, indicating bidirectional hormonal control. Microgravity activates monocyte ERK1/2 signaling and modulates the response to LPS, showing that mechanical and environmental cues regulate the pathway. Host genetic background, such as breed in ewes, influences the magnitude of the response. Disease state also matters: monocytes from hypertensive coronary artery disease patients show an attenuated LPS response driven by a specific gene network. Metabolic status further shapes the response, as seen in human alveolar macrophages. Together, these findings show that GO:0071222 is not a fixed program but a regulated, context-dependent process.

cellular response to lipopolysaccharide and Human Disease

GeneDisease / BiologyPotential Experimental Model
Monocyte gene network genesHypertensive coronary artery diseasePatient-derived monocytes with CRISPR knockout
VDRInflammatory modulation by vitamin DKnockout and overexpression in macrophage lines
ERK1/2 (MAPK3/MAPK1)Microgravity-associated immune modulationPoint-mutation and knockout in monocytes
Metabolic pathway enzymesAlveolar macrophage metabolic reprogrammingKnockout in iPSC-derived macrophages
Cytokine genes (TNF, IL6)Inflammatory and infectious diseaseKnock-in reporter and knockout models
Coronary artery disease and hypertension
Monocytes from hypertensive coronary artery disease patients display an attenuated response to lipopolysaccharide, driven by a specific gene network. This suggests that the cellular response to LPS is reprogrammed in cardiovascular disease and may contribute to altered inflammatory tone.
Metabolic and muscle stress
LPS-induced cell stress in myotubes is accompanied by fluctuations in adenine-derived signaling molecules and cytokinins, linking the cellular response to LPS with muscle metabolic stress. In human alveolar macrophages, LPS exposure reveals metabolic pathway changes relevant to lung immunity and metabolic disease.
Inflammatory and infectious disease
The cellular response to LPS is central to innate immune activation by gram-negative bacteria. Human macrophage-like cells respond to Fusobacterium nucleatum lipopolysaccharide, illustrating how different bacterial LPS structures can drive inflammatory outputs. Vitamin D can both facilitate and attenuate this response, highlighting potential nutritional modulation of inflammation.

From cellular response to lipopolysaccharide-Related Genes to Experimental Models

Research QuestionSuitable Model
Is a candidate gene required for LPS-induced cytokine secretion?CRISPR knockout in macrophage or monocyte cell line
Does a specific point mutation alter LPS signaling?CRISPR point mutation (base editing or HDR)
Does a risk variant change LPS response?Knock-in of the variant allele
Where does a protein localize after LPS stimulation?Tagged knock-in with fluorescent or epitope tag
Does overexpression of a gene amplify the LPS response?CRISPR overexpression (e.g., CRISPRa)
Which genes drive an attenuated LPS response?CRISPR library screening in patient-derived monocytes

How to Study the cellular response to lipopolysaccharide Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal gene expression changes after LPSDefining gene networks in GO:0071222
Phosphoproteomics / immunoblotKinase signaling activation (e.g., ERK1/2)Early signaling after LPS
MetabolomicsMetabolic pathway shifts after LPSAlveolar macrophage metabolic remodeling
Cytokine ELISASecreted effector proteinsFunctional output of LPS response
Flow cytometryCell-surface markers and cell subpopulation responsesHaemocyte and monocyte responses
Live-cell imagingMovement, secretion and localizationCell-autonomous response to LPS
CRISPR screeningCausal genes required for LPS responseGene network discovery
Small-molecule profilingAdenine-derived signaling molecules and cytokininsLPS-induced cell stress in myotubes
Transcriptomic profiling
RNA-seq after LPS stimulation is widely used to define the cellular response to lipopolysaccharide. This approach identified a gene network driving the attenuated LPS response in monocytes from hypertensive coronary artery disease patients and revealed metabolic pathway changes in human alveolar macrophages. Transcriptomic profiling is therefore a primary method for annotating GO:0071222.
Signaling and phosphoproteomics
Kinase signaling is an early feature of the LPS response. Microgravity-activated ERK1/2 signaling and its modulation of the LPS response were studied using signaling assays in monocytes. Phosphoproteomics and immunoblotting can quantify these early events and link them to downstream gene expression.
Metabolic and small-molecule profiling
Metabolic remodeling is part of GO:0071222. Studies in human alveolar macrophages uncovered metabolic pathways in response to LPS, and profiling of adenine-derived signaling molecules in myotubes revealed fluctuations under LPS-induced cell stress. Metabolomics and targeted small-molecule assays are therefore valuable for studying this term.
Functional and secretion assays
Secretory outputs define the effector phase of the cellular response to LPS. Human macrophage-like cells stimulated with Fusobacterium nucleatum LPS were used to measure cellular responses, and different shrimp haemocyte subpopulations showed various responses to LPS stimulation. Cytokine ELISAs, flow cytometry and live-cell imaging are typical functional readouts.

How CRISPR Can Be Used to Study GO:0071222 cellular response to lipopolysaccharide

Knockout

CRISPR knockout is used to test whether a candidate gene is required for the cellular response to lipopolysaccharide. For example, knocking out genes in the monocyte gene network could confirm their role in the attenuated LPS response seen in hypertensive coronary artery disease patients. Knockout of VDR or signaling kinases can reveal their contribution to LPS-induced gene expression.

Point Mutation

CRISPR point mutation allows precise testing of amino acid residues or regulatory variants. For instance, point mutations in ERK1/2 pathway components could clarify how microgravity modulates LPS signaling. Point mutations can also model disease-associated variants that alter the LPS response.

Knock-in

Knock-in models are used to introduce tags, reporters or disease variants. A tagged knock-in of a metabolic enzyme could reveal its localization after LPS stimulation in alveolar macrophages. Knock-in of a risk allele can test whether it changes the cellular response to LPS.

Overexpression

CRISPR overexpression (e.g., CRISPRa) is used to ask whether increasing a gene's activity amplifies or dampens the LPS response. Overexpression of vitamin D pathway components could test their dual facilitating and attenuating roles. Overexpression of cytokine genes can model excessive inflammatory output after LPS.

How EDITGENE Supports cellular response to lipopolysaccharide Research

Researchers studying cellular response to lipopolysaccharide-related genes often need to determine whether a candidate gene is causally involved in LPS sensing, signaling or effector output. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of these hypotheses in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for cellular response to lipopolysaccharide research.

Frequently Asked Questions About cellular response to lipopolysaccharide

GO:0071222 is a Gene Ontology biological process term describing any change in a cell's state or activity, such as movement, secretion, enzyme production or gene expression, in response to lipopolysaccharide, a major component of the gram-negative bacterial cell wall.
Genes involved include ERK1/2 signaling components, vitamin D receptor pathway genes, NF-kB-related transcription factors, cytokine genes and metabolic pathway enzymes, as shown in monocytes, macrophages and myotubes.
LPS triggers early signaling such as ERK1/2 activation, followed by transcriptional reprogramming and metabolic remodeling, leading to secretion of cytokines and other effectors.
It is central to innate immune activation and is altered in conditions such as hypertensive coronary artery disease, where monocytes show an attenuated LPS response driven by a specific gene network.
Yes, vitamin D both facilitates and attenuates the cellular response to LPS, indicating bidirectional modulation of inflammatory gene expression.
Common methods include RNA-seq, phosphoproteomics, metabolomics, cytokine ELISAs, flow cytometry and CRISPR screening in relevant cell models.
Yes, CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes involved in the cellular response to LPS.
Yes, different cell types such as monocytes, alveolar macrophages, myotubes and shrimp haemocyte subpopulations show distinct responses to LPS stimulation.
Metabolic remodeling, including changes in amino acid, lipid and energy pathways, is a core feature of the cellular response to LPS in human alveolar macrophages.
Microgravity activates monocyte ERK1/2 signaling and modulates the response to lipopolysaccharide, showing that environmental conditions can alter this process.

Conclusion

GO:0071222 cellular response to lipopolysaccharide is a fundamental biological process that describes how individual cells sense and react to a major gram-negative bacterial cell wall component. The verified literature shows that this response involves early signaling, transcriptional reprogramming, metabolic remodeling and secretory outputs, and that it varies by cell type, host genetics, disease state and environmental context. Studying GO:0071222 with CRISPR-based models and multi-omics methods will continue to reveal causal mechanisms and therapeutic opportunities in inflammation and metabolic disease.

References

  1. 1. Chen L et al.. 2017. Vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide.. Sci Rep 7:45172 PMID: 28345644
  2. 2. van Linge CCA et al.. 2025. Uncovering metabolic pathways in human alveolar macrophages in response to lipopolysaccharide.. Clin Exp Immunol 219(1) PMID: 40515396
  3. 3. Lu C et al.. 2024. Identification of a gene network driving the attenuated response to lipopolysaccharide of monocytes from hypertensive coronary artery disease patients.. Front Immunol 15:1286382 PMID: 38410507
  4. 4. Tobin SW et al.. 2023. Profiling of adenine-derived signaling molecules, cytokinins, in myotubes reveals fluctuations in response to lipopolysaccharide-induced cell stress.. Physiol Rep 11(23):e15870 PMID: 38040455
  5. 5. Hadfield JM et al.. 2018. Breed-specific differences in the immune response to lipopolysaccharide in ewes.. J Anim Sci 96(10):4220-4228 PMID: 30107562
  6. 6. Mammadov RA et al.. 2025. Microgravity activates monocyte ERK1/2 signaling and modulates the response to lipopolysaccharide.. Mol Med 32(1):2 PMID: 41318416
  7. 7. Xian JA et al.. 2017. Various cellular responses of different shrimp haemocyte subpopulations to lipopolysaccharide stimulation.. Fish Shellfish Immunol 69:195-199 PMID: 28842372
  8. 8. Grenier D et al.. 2006. Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide.. Oral Microbiol Immunol 21(3):190-6 PMID: 16626377
Contact Us
*
*
*
*
How did you hear about us: